Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003
NCT01992367
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
ASLAN003 ACTIVE
Sponsor
ASLAN Pharmaceuticals